Neurostimulation treatments for epilepsy: Deep brain stimulation, responsive neurostimulation and vagus nerve stimulation

Методы нейростимуляции при эпилепсии: глубокая стимуляция мозга, реагирующая нейростимуляция и стимуляция блуждающего нерва
George M. Ibrahim, Hrishikesh Suresh, Nebras M. Warsi, Flavia Venetucci Gouveia, Rafi Matin
2024-01-04

NeuroQuery and NeuroSynthdeep brain stimulationdrug-resistant epilepsyresponsive neurostimulationvagus nerve stimulation
Epilepsy is a common and debilitating neurological disorder, and approximately one-third of affected individuals have ongoing seizures despite appropriate trials of two anti-seizure medications. This population with drug-resistant epilepsy (DRE) may benefit from neurostimulation approaches, such as vagus nerve stimulation (VNS), deep brain stimulation (DBS) and responsive neurostimulation (RNS). In some patient populations, these techniques are FDA-approved for treating DRE. VNS is used as adjuvant therapy for children and adults. Acting via the vagus afferent network, VNS modulates thalamocortical circuits, reducing seizures in approximately 50 ​% of patients. RNS uses an adaptive (closed-loop) system that records intracranial EEG patterns to activate the stimulation at the appropriate time, being particularly well-suited to treat seizures arising within eloquent cortex. For DBS, the most promising therapeutic targets are the anterior and centromedian nuclei of the thalamus, with anterior nucleus DBS being used for treating focal and secondarily generalized forms of DRE and centromedian nucleus DBS being applied for treating generalized epilepsies such as Lennox-Gastaut syndrome. Here, we discuss the indications, advantages and limitations of VNS, DBS and RNS in treating DRE and summarize the spatial distribution of neuroimaging observations related to epilepsy and stimulation using NeuroQuery and NeuroSynth.
1
Approximately one-third of people with epilepsy have drug-resistant seizures despite appropriate trials of two anti-seizure medications.
2
Deep brain stimulation targets the anterior and centromedian thalamic nuclei for different drug-resistant epilepsy types, including focal, secondarily generalized, and generalized epilepsies such as Lennox-Gastaut syndrome.
3
Responsive neurostimulation uses intracranial EEG in a closed-loop system to deliver stimulation at seizure-relevant times and is particularly suitable for seizures arising in eloquent cortex.
4
The review compares indications, advantages, and limitations of VNS, DBS, and RNS and maps related neuroimaging observations using NeuroQuery and NeuroSynth.
5
Vagus nerve stimulation is an adjunctive treatment for children and adults, reducing seizures in approximately 50% of patients through vagal afferent modulation of thalamocortical circuits.

Neurostimulation treatments for drug-resistant epilepsy, including vagus nerve stimulation, deep brain stimulation, and responsive neurostimulation

The indications, therapeutic effects, mechanisms, advantages, and limitations of VNS, DBS, and RNS for reducing seizures across different drug-resistant epilepsy populations

Publication Details
Publication Date
2024-01-04
Journal
Publisher
ISSN
Cited by
128
Access Type
Author Information
Authors
George M. Ibrahim
Hrishikesh Suresh
Nebras M. Warsi
Flavia Venetucci Gouveia
Rafi Matin
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%